Skip to main content
Menu
search

Navigating the Digital Frontier: Considerations for Decentralized Manufacturing of Advanced Therapies

Navigating the Digital Frontier: Considerations for Decentralized Manufacturing of Advanced Therapies

Industry:
Biopharma

Type:
Podcast

Location:
Miami, Florida

The second panel features insights from Forrest Brown (VP Client Services, Germfree) and Krisha Patel (Co-Founder, Assurea), as they delve into the intricacies of decentralized manufacturing. They discuss key regulatory considerations and validation strategies for the decentralized manufacturing of gene therapies. Looking ahead, they anticipate a future where cybersecurity becomes a paramount focus, and interconnected systems enable better process characterization and real-time release of products. Watch the full session, below.

You might also be interested in

Video

Inside the Innovation: Mobile CL-2 Laboratory Walkthrough

Discover how our team's design and engineering efforts have created a versatile solution for various processes and applications.
Articles

Optimizing Pharmaceutical Isolator Design

This article delves into the world of isolators, exploring their importance in the pharmaceutical and biotech industries, the challenges of innovating aseptic isolator design, best practices, key aspects of design…
Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing
Video

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Dive into this discussion around decentralized manufacturing and the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.

Contact us: Let's unlock your scientific potential together

Complete our contact form and a member of our commercial team will contact you within 24 hours.

White email icon on a green diamond

Service & support: cs@germfree.com